A detailed history of Independent Investors Inc transactions in Baxter International Inc stock. As of the latest transaction made, Independent Investors Inc holds 5,635 shares of BAX stock, worth $187,138. This represents 0.04% of its overall portfolio holdings.

Number of Shares
5,635
Previous 7,635 26.2%
Holding current value
$187,138
Previous $255,000 16.47%
% of portfolio
0.04%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$32.85 - $40.26 $65,700 - $80,520
-2,000 Reduced 26.2%
5,635 $213,000
Q2 2023

Jul 19, 2023

SELL
$39.98 - $47.68 $668,665 - $797,448
-16,725 Reduced 68.66%
7,635 $347,000
Q4 2022

Feb 02, 2023

SELL
$49.7 - $57.71 $49,700 - $57,710
-1,000 Reduced 3.94%
24,360 $1.24 Million
Q3 2022

Oct 24, 2022

SELL
$53.86 - $66.8 $31,238 - $38,744
-580 Reduced 2.24%
25,360 $1.37 Million
Q1 2020

Apr 06, 2020

SELL
$71.57 - $93.3 $21,470 - $27,990
-300 Reduced 1.14%
25,940 $2.11 Million
Q4 2019

Jan 15, 2020

SELL
$76.7 - $88.45 $115,050 - $132,675
-1,500 Reduced 5.41%
26,240 $2.19 Million
Q3 2019

Oct 31, 2019

SELL
$81.4 - $89.78 $159,544 - $175,968
-1,960 Reduced 6.6%
27,740 $2.43 Million
Q1 2019

May 01, 2019

SELL
$64.48 - $81.31 $96,720 - $121,965
-1,500 Reduced 4.81%
29,700 $2.41 Million
Q4 2018

Jan 14, 2019

SELL
$61.45 - $77.8 $36,870 - $46,680
-600 Reduced 1.89%
31,200 $2.05 Million
Q2 2018

Aug 09, 2018

SELL
$63.43 - $75.41 $25,372 - $30,164
-400 Reduced 1.24%
31,800 $2.35 Million
Q4 2017

Jan 30, 2018

SELL
$61.45 - $66.05 $12,290 - $13,210
-200 Reduced 0.62%
32,200 $2.08 Million
Q3 2017

Oct 24, 2017

BUY
$59.5 - $64.61 $1.93 Million - $2.09 Million
32,400
32,400 $2.03 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Independent Investors Inc Portfolio

Follow Independent Investors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Investors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Independent Investors Inc with notifications on news.